Annual Current Liabilities
$5.29 M
-$2.60 M-32.92%
December 31, 2023
Summary
- As of February 6, 2025, HEPA annual total current liabilities is $5.29 million, with the most recent change of -$2.60 million (-32.92%) on December 31, 2023.
- During the last 3 years, HEPA annual current liabilities has risen by +$628.30 thousand (+13.48%).
- HEPA annual current liabilities is now -35.54% below its all-time high of $8.21 million, reached on December 31, 2021.
Performance
HEPA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.72 M
+$1.74 M+178.39%
September 30, 2024
Summary
- As of February 6, 2025, HEPA quarterly total current liabilities is $2.72 million, with the most recent change of +$1.74 million (+178.39%) on September 30, 2024.
- Over the past year, HEPA quarterly current liabilities has dropped by -$3.69 million (-57.58%).
- HEPA quarterly current liabilities is now -79.70% below its all-time high of $13.38 million, reached on June 30, 2022.
Performance
HEPA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
HEPA Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.9% | -57.6% |
3 y3 years | +13.5% | -66.9% |
5 y5 years | +85.6% | -66.9% |
HEPA Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -35.5% | at low | -79.7% | +178.4% |
5 y | 5-year | -35.5% | +228.7% | -79.7% | +178.4% |
alltime | all time | -35.5% | +2228.4% | -79.7% | +945.0% |
Hepion Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.72 M(+178.4%) |
Jun 2024 | - | $975.60 K(-62.1%) |
Mar 2024 | - | $2.57 M(-51.3%) |
Dec 2023 | $5.29 M(-32.9%) | $5.29 M(-17.4%) |
Sep 2023 | - | $6.40 M(-16.6%) |
Jun 2023 | - | $7.67 M(-21.7%) |
Mar 2023 | - | $9.80 M(+24.3%) |
Dec 2022 | $7.89 M(-3.9%) | $7.89 M(+5.3%) |
Sep 2022 | - | $7.49 M(-44.0%) |
Jun 2022 | - | $13.38 M(+113.7%) |
Mar 2022 | - | $6.26 M(-23.7%) |
Dec 2021 | $8.21 M(+76.0%) | $8.21 M(+15.9%) |
Sep 2021 | - | $7.08 M(-0.3%) |
Jun 2021 | - | $7.10 M(+147.7%) |
Mar 2021 | - | $2.87 M(-38.5%) |
Dec 2020 | $4.66 M(+189.6%) | $4.66 M(+17.8%) |
Sep 2020 | - | $3.96 M(+52.0%) |
Jun 2020 | - | $2.60 M(+69.5%) |
Mar 2020 | - | $1.54 M(-4.6%) |
Dec 2019 | $1.61 M(-43.5%) | $1.61 M(+6.9%) |
Sep 2019 | - | $1.51 M(-16.3%) |
Jun 2019 | - | $1.80 M(-48.0%) |
Mar 2019 | - | $3.46 M(+21.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $2.85 M(+9.5%) | $2.85 M(-49.6%) |
Sep 2018 | - | $5.65 M(+13.1%) |
Jun 2018 | - | $5.00 M(+95.1%) |
Mar 2018 | - | $2.56 M(-8.8%) |
Dec 2017 | $2.60 M(-11.6%) | - |
Sep 2017 | - | $2.81 M(-4.6%) |
Jun 2017 | $2.94 M(-42.1%) | $2.94 M(+19.1%) |
Mar 2017 | - | $2.47 M(-23.3%) |
Dec 2016 | - | $3.22 M(-37.5%) |
Sep 2016 | - | $5.16 M(+1.5%) |
Jun 2016 | $5.08 M(+162.3%) | $5.08 M(+18.5%) |
Mar 2016 | - | $4.29 M(+14.0%) |
Dec 2015 | - | $3.76 M(-10.8%) |
Sep 2015 | - | $4.21 M(+117.5%) |
Jun 2015 | $1.94 M(+322.5%) | $1.94 M(+20.0%) |
Mar 2015 | - | $1.62 M(+347.6%) |
Dec 2014 | - | $361.00 K(-22.3%) |
Sep 2014 | - | $464.70 K(+1.3%) |
Jun 2014 | $458.70 K(+101.9%) | $458.70 K(+76.5%) |
Mar 2014 | - | $259.90 K(-47.9%) |
Dec 2013 | - | $498.70 K(+25.1%) |
Sep 2013 | - | $398.60 K |
Jun 2013 | $227.20 K | - |
FAQ
- What is Hepion Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual current liabilities year-on-year change?
- What is Hepion Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly current liabilities year-on-year change?
What is Hepion Pharmaceuticals annual total current liabilities?
The current annual current liabilities of HEPA is $5.29 M
What is the all time high annual current liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual total current liabilities is $8.21 M
What is Hepion Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, HEPA annual total current liabilities has changed by -$2.60 M (-32.92%)
What is Hepion Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of HEPA is $2.72 M
What is the all time high quarterly current liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly total current liabilities is $13.38 M
What is Hepion Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, HEPA quarterly total current liabilities has changed by -$3.69 M (-57.58%)